Modulation of Anti-tumor T Cell Responses in Cancer Patients Treated by Concomitant Radiochemotherapy

Once Daily Accelerated Fractionation With Concomitant Boost to the Gross Tumor Volume Compared With Twice Daily Hyperfractionation in Concurrent Chemoradiation in Patients With Limited Disease Small Cell Lung Cancer

NCT01710956 ·Status: UNKNOWN ·Phase: PHASE2

High Dose Intensity Modulated Radiation Therapy in the Cervical Cancer With Metastatic Lymphadenopathies.

NCT01730651 ·Status: UNKNOWN ·Phase: NA

Cancer Patients Treated With Immunotherapy in Intensive Care Unit

NCT03357861 ·Status: COMPLETED

Radiotherapy Dose Complement in the Treatment of Hypoxic Lesions Patients With Stage III Non-small-cell Lung Cancer

NCT01576796 ·Status: UNKNOWN ·Phase: PHASE2

Tumor Response in Hypofractionated Radiotherapy

NCT02854449 ·Status: UNKNOWN

Hypofractionated Radiation Therapy to Improve Immunotherapy Response in Non-Small Cell Lung Cancer

NCT03035890 ·Status: COMPLETED ·Phase: NA

Feasibility of Immunotherapy Plus Chemotherapy Administration to Patients With Bronchial Cancer in a Hospital-at- Home Setting

NCT04802902 ·Status: COMPLETED

Re-Induction After Initial Response With Immune Therapy With Radiotherapy in Lung Cancer

NCT03406468 ·Status: COMPLETED ·Phase: PHASE2

Isotoxic Intensity Modulated Radiotherapy (IMRT) in Stage III Non Small Cell Lung Cancer (NSCLC) - A Feasibility Study

NCT01836692 ·Status: COMPLETED ·Phase: NA

Radio-Immuno-Modulation in Lung Cancer

NCT02579005 ·Status: SUSPENDED ·Phase: PHASE1

Immunotherapy Clearance and Phenotype of Circulating Tumor Cells in Lung and Head and Neck Cancers

NCT05091190 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

Circulating Immunes Cells, Cytokines and Brain Radiotherapy

NCT05082961 ·Status: RECRUITING ·Phase: NA

Early Biomarkers of Tumor Response in High Dose Hypofractionated Radiotherapy Word Package 3 : Immune Response

NCT02439008 ·Status: TERMINATED ·Phase: NA

Feasibility of Immunotherapy Administration to Patients With Bronchial Cancer in a Hospital-at- Home Setting (ImHADom)

NCT03786653 ·Status: COMPLETED

Survival Efficacy of Combined Radiotherapy and Immunotherapy in Patients With Metastatic Non-small Cell Lung Carcinoma

NCT07111104 ·Status: COMPLETED

Moderate Hypofractionated Radiotherapy for Lung Cancer

NCT03833193 ·Status: UNKNOWN ·Phase: NA

RT for Adenocarcinoma/Adenosquamous Carcinoma

NCT07153952 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

UCDCC#269: A Pilot Study of Interlesional IL-2 and RT in Patients With NSCLC.

NCT03224871 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Anti PD-1 Antibody With Radiation Therapy in Patients With HER2-negative Metastatic Breast Cancer

NCT03430479 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Immunological Function After Radiation With Either Proton or Photon Therapy

NCT06016699 ·Status: UNKNOWN

Stereotactic Body Radiation Therapy (SBRT) in Metastatic Non-small Cell Lung Cancer

NCT01185639 ·Status: COMPLETED ·Phase: NA

Radiotherapy Treatments for the Treatment of Thoracic District Tumors

NCT06335290 ·Status: RECRUITING

Immune Responses in Prostate, Lung, Melanoma and Breast Cancer Patients Following Stereotactic Body Radiotherapy (SBRT), Intensity Modulated Radiotherapy (IMRT) or Brachytherapy

NCT01777802 ·Status: COMPLETED

Detection of Circulating Biomarkers of Immunogenic Cell Death

NCT02921854 ·Status: COMPLETED ·Phase: NA

Phase II Study of Intensity Modulated Radiotherapy in Dose Painting for Sinus Carcinomas After Endoscopic Surgery

NCT05943119 ·Status: RECRUITING ·Phase: PHASE2